MARKET

MCET

MCET

Multicell Technologies Inc
EXMKT
0.0001
NaN%
Closed 09:30 05/22 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
500.09K
P/E (TTM)
-1.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MCET last week (0512-0516)?
Weekly Report · 3d ago
Weekly Report: what happened at MCET last week (0505-0509)?
Weekly Report · 05/12 11:54
Weekly Report: what happened at MCET last week (0428-0502)?
Weekly Report · 05/05 11:57
Weekly Report: what happened at MCET last week (0421-0425)?
Weekly Report · 04/28 12:09
Weekly Report: what happened at MCET last week (0414-0418)?
Weekly Report · 04/21 12:08
Weekly Report: what happened at MCET last week (0407-0411)?
Weekly Report · 04/14 11:54
Weekly Report: what happened at MCET last week (0331-0404)?
Weekly Report · 04/07 11:54
Weekly Report: what happened at MCET last week (0324-0328)?
Weekly Report · 03/31 12:09
More
About MCET
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company. The Company and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The Company's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development, and includes MCT-125, MCT-465, MCT-475 and MCT-485. MCT-125 is a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue. MCT-465 is a preclinical synthetic double-stranded ribonucleic acid (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers. MCT-475 is a discovery-stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers. MCT-485 is a discovery-stage dsRNA therapeutic candidate for the treatment of certain cancers.

Webull offers Multicell Technologies Inc stock information, including EXMKT: MCET real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCET stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MCET stock methods without spending real money on the virtual paper trading platform.